Htg Molecular Diagnostics Inc Quick Ratio (HTGM) starting from the first quarter 2023 to first quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Htg Molecular Diagnostics Inc  (NASDAQ: HTGM)

Htg Molecular Diagnostics Inc's Quick Ratio

HTGM's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the first quarter 2023, Quick Ratio deteriorated to 1 below Htg Molecular Diagnostics Inc's average Quick Ratio.

Within Laboratory Analytical Instruments industry 23 other companies have achieved higher Quick Ratio than Htg Molecular Diagnostics Inc in first quarter 2023. While Quick Ratio total ranking in the first quarter 2023 has deteriorated compared to the prior quarter from 1533 to 2162.

Explain Quick Ratio?
How much Cash & cash equivalents HTGM´s has?
What are HTGM´s Current Liabilities?




HTGM Quick Ratio (Mar 31 2023)
Q1
(Dec 31 2022)
Q4
(Sep 30 2022)
Q3
(Jun 30 2022)
Q2
(Mar 31 2022)
Q1
Y / Y Current Liabilities Change -13.64 % -26.38 % 3.45 % 70.77 % 3.97 %
Y / Y Cash & cash equivalent Change -69.56 % -44.35 % -74.31 % -52.62 % -29.91 %
Quick Ratio MRQ 1 1.48 0.96 1.39 2.84
HTGM's Total Ranking # 2162 # 1533 # 2061 # 2095 # 1229
Seq. Current Liabilities Change -20.7 % 21.26 % -32.86 % 33.77 % -32.4 %
Seq. Cash & cash equivalent Change -46.25 % 86.99 % -53.68 % -34.62 % -1.73 %



Quick Ratio first quarter 2023 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 24
Healthcare Sector # 831
Overall Market # 2162


Quick Ratio Statistics
High Average Low
9.8 3.57 0.24
(Mar 31 2018)   (Mar 31 2015)




Financial Statements
Htg Molecular Diagnostics Inc's Current Liabilities $ 7 Millions Visit HTGM's Balance sheet
Htg Molecular Diagnostics Inc's Cash & cash equivalent $ 7 Millions Visit HTGM's Balance sheet
Source of HTGM's Sales Visit HTGM's Sales by Geography


Cumulative Htg Molecular Diagnostics Inc's Quick Ratio

HTGM's Quick Ratio for the trailling 12 Months

HTGM Quick Ratio

(Mar 31 2023)
12 Months
(Dec 31 2022)
12 Months
(Sep 30 2022)
12 Months
(Jun 30 2022)
12 Months
(Mar 31 2022)
12 Months
Y / Y Current Liabilities TTM Growth 1.4 % 5.68 % 24.87 % 32.91 % 26.09 %
Y / Y Cash & cash equivalent TTM Growth -60.07 % -49.57 % -44.05 % -30.66 % -19.67 %
Quick Ratio TTM 1.24 1.66 1.79 2.33 3.15
Total Ranking TTM # 4752 # 4433 # 4056 # 1323 # 4295
Seq. Current Liabilities TTM Growth -3.15 % -8.28 % 0.64 % 13.42 % 0.93 %
Seq. Cash & cash equivalent TTM Growth -27.57 % -15.18 % -22.75 % -15.87 % -8.53 %


On the trailing twelve months basis In spite of the year on year decrease in HTGM's Current Liabilities to $6.56 millions, cumulative Quick Ratio to 1.24 below the HTGM average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 32 other companies have achieved higher Quick Ratio than Htg Molecular Diagnostics Inc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2022 from 4433 to 4752.

Explain Quick Ratio?
How much Cash & cash equivalents HTGM´s has?
What are HTGM´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 33
Healthcare Sector # 1193
Within the Market # 4752


trailing twelve months Quick Ratio Statistics
High Average Low
6.74 3.21 0.8
(Dec 31 2018)   (Dec 31 2017)




Companies with similar Quick Ratio in the quarter ending Mar 31 2023, within Laboratory Analytical Instruments Industry Quick RatioMar 31 2023 MRQ Cash & cash equivalentMar 31 2023 MRQ Current Liabilities
Cue Health Inc   2.64 $ 178.201  Millions$ 67.458  Millions
Bionano Genomics Inc   2.51 $ 95.808  Millions$ 38.135  Millions
Lifeloc Technologies Inc   2.38 $ 2.052  Millions$ 0.862  Millions
Olink Holding Ab publ   2.18 $ 120.957  Millions$ 55.487  Millions
Scientific Industries Inc   2.08 $ 4.458  Millions$ 2.139  Millions
Telesis Bio Inc   2.08 $ 23.357  Millions$ 11.240  Millions
Akoya Biosciences Inc   1.81 $ 60.247  Millions$ 33.223  Millions
Prenetics Global Limited  1.16 $ 45.706  Millions$ 39.484  Millions
Phenomex Inc   1.07 $ 51.606  Millions$ 48.230  Millions
Htg Molecular Diagnostics Inc  1.00 $ 6.563  Millions$ 6.559  Millions
Agilent Technologies inc   0.88 $ 1,175.000  Millions$ 1,335.000  Millions
Bruker Corporation  0.57 $ 597.900  Millions$ 1,048.500  Millions
Thermogenesis Holdings Inc   0.56 $ 5.854  Millions$ 10.471  Millions
Precipio inc   0.53 $ 2.141  Millions$ 4.017  Millions
Accelerate Diagnostics Inc   0.47 $ 29.408  Millions$ 62.803  Millions
Kewaunee Scientific Corporation  0.34 $ 13.815  Millions$ 40.053  Millions

Date modified: 2026-09-08T15:10:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.